Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: Differences between men and women

Cytokine

Volumn 48, Issue 3, 2009, Pages 260-266

  Sjöholm, Kajsa ^a   Lundgren, Magdalena ^b   Olsson, Maja ^a   Eriksson, Jan W ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipocyte size; Adipokines; C reactive protein; Serum amyloid A

Indexed keywords

ADIPOCYTOKINE; AMYLOID A PROTEIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; BODY FAT; CELL ENLARGEMENT; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADIPOCYTES; ADIPOKINES; BODY MASS INDEX; C-REACTIVE PROTEIN; CELL SIZE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; SERUM AMYLOID A PROTEIN; SEX FACTORS;

EID: 70350134242     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.08.005     Document Type: Article

References (36)

1. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
2. Das U.N. Is obesity an inflammatory condition?. Nutrition 17 (2001) 953-966
3. Rajala M.W., and Scherer P.E. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
4. Montague C.T., and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 (2000) 883-888
5. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., and Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43 (2000) 1498-1506
6. Salans L.B., Knittle J.L., and Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 47 (1968) 153-165
7. Salans L.B., and Dougherty J.W. The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. J Clin Invest 50 (1971) 1399-1410
8. Lundgren M., Svensson M., Lindmark S., Renström F., Ruge T., and Eriksson J.W. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 50 (2007) 625-633
9. Winkler G., Kiss S., Keszthelyi L., Sapi Z., Ory I., Salamon F., et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149 (2003) 129-135
10. Van Harmelen V., Reynisdottir S., Eriksson P., Thorne A., Hoffstedt J., Lönnqvist F., et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47 (1998) 913-917
11. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 12 (2004) 454-460
12. Skurk T., Alberti-Huber C., Herder C., and Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92 (2007) 1023-1033
13. Smith U. Studies of human adipose tissue in culture. I. Incorporation of glucose and release of glycerol. Anat Rec 172 (1972) 597-602
14. Engfeldt P., and Arner P. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res Suppl 19 (1988) 26-29
15. Despres J.P., Fong B.S., Julien P., Jimenez J., and Angel A. Regional variation in HDL metabolism in human fat cells: effect of cell size. Am J Physiol 252 (1987) E654-E659
16. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Yee G., Lamendola C., et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 50 (2007) 1707-1715
17. Sethi J.K., and Vidal-Puig A.J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48 (2007) 1253-1262
18. Lelliott C., and Vidal-Puig A.J. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int J Obes Relat Metab Disord 28 Suppl. 4 (2004) S22-S28
19. Sjöholm K., Palming J., Olofsson L.E., Gummesson A., Svensson P.A., Lystig T.C., et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 90 (2005) 2233-2239
20. Jernås M., Palming J., Sjöholm K., Jennische E., Svensson P.A., Gabrielsson B.G., et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20 (2006) 1540-1542
21. Clement K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C.A., et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18 (2004) 1657-1669
22. Walder K., Kantham L., McMillan J.S., Trevaskis J., Kerr L., De Silva A., et al. Tanis: a link between type 2 diabetes and inflammation?. Diabetes 51 (2002) 1859-1866
23. Cheng N., He R., Tian J., Ye P.P., and Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181 (2008) 22-26
24. Johnson B.D., Kip K.E., Marroquin O.C., Ridker P.M., Kelsey S.F., Shaw L.J., et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 726-732
25. Yang R.Z., Lee M.J., Hu H., Pollin T.I., Ryan A.S., Nicklas B.J., et al. Acute-phase serum amyloid A: an inflammatory adipokine, potential link between obesity, its metabolic complications. PLoS Med 3 (2006) e287
26. Poitou C., Coussieu C., Rouault C., Coupaye M., Cancello R., Bedel J.F., et al. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring) 14 (2006) 309-318
27. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
28. Lukaski H.C., Bolonchuk W.W., Hall C.B., and Siders W.A. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60 (1986) 1327-1332
29. Lindmark S., Buren J., and Eriksson J.W. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo. Clin Endocrinol (Oxf) 65 (2006) 301-309
30. Lindmark S., Wiklund U., Bjerle P., and Eriksson J.W. Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects. Diabet Med 20 (2003) 399-405
31. van Dielen F.M., van't Veer C., Schols A.M., Soeters P.B., Buurman W.A., and Greve J.W. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 25 (2001) 1759-1766
32. Lappalainen T., Kolehmainen M., Schwab U., Pulkkinen L., Laaksonen D.E., Rauramaa R., et al. Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study. Eur J Endocrinol 158 (2008) 333-341
33. Wakatsuki A., Ikenoue N., Shinohara K., Watanabe K., and Fukaya T. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 24 (2004) 571-576
34. Leinonen E., Hurt-Camejo E., Wiklund O., Hulten L.M., Hiukka A., and Taskinen M.R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166 (2003) 387-394
35. Hagihara K., Nishikawa T., Isobe T., Song J., Sugamata Y., and Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun 314 (2004) 363-369
36. Hickey M.S., Israel R.G., Gardiner S.N., Considine R.V., McCammon M.R., Tyndall G.L., et al. Gender differences in serum leptin levels in humans. Biochem Mol Med 59 (1996) 1-6